wegovy liver disease - Search News

Order byBest matchMost fresh

Liver Disease, Food and Drug Administration

A Common Weight Loss Drug Can Treat Severe Liver Disease, F.D.A. Says

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on Friday.

· 6h · on MSN

Novo Nordisk's Weight-Loss Drug Wegovy Approved to Treat Liver Disease

Managed Healthcare Executive · 5h

FDA Grants Accelerated Approval of Wegovy to Treat Liver Disease

· 1d

Novo Nordisk’s Wegovy Gets US Approval for Liver Disease

Novo Nordisk A/S's Wegovy received Food and Drug Administration approval to treat metabolic-associated steatohepatitis in adults with moderate to advanced scar tissue in the liver.

· 5h

Why Nova Nordisk (NVO) Stock Is Climbing Today

· 8h

Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease

· 10h

Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment

"It is expected that this market exclusivity will only last for a transitional phase before Eli Lilly also launches a product on the market," said Nordnet analyst Per Hansen.

· 4h

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

· 8h

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease

11h

Novo Advances After US Clears Wegovy for Liver Disease

Novo Nordisk A/S shares advanced after the drugmaker’s blockbuster weight-loss drug Wegovy received US approval to treat a serious form of liver disease, beating rival Eli Lilly & Co. to the US market.

Medscape7h

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis but without cirrhosis.

Liver Disease, Food and Drug Administration

Novo Advances After US Clears Wegovy for Liver Disease

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Related topics